JUPITER MEDICAL CENTER PARTNERS WITH SCRIPPS RESEARCH FOR BREAST AND LUNG CANCER CLINICAL RESEARCH TRIAL

June 4, 2014

FOR IMMEDIATE RELEASE
 

Media contact:
Heather Robbins
(561) 630-7739
Heather@sbrandstrategies.com
 

JUPITER, FLA. (JUNE 4, 2014) Jupiter Medical Center has partnered with Scripps Florida, a division of The Scripps Research Institute, to conduct a clinical trial from surgical tissue specimens of the breast and the lung to identify targets for development and testing of therapeutics. Results from the trial will help the medical community better understand how therapies work and how to most effectively manage and treat cancers.


Eligibility is voluntary and open to participants who are over the age of 18, will undergo a tissue biopsy or surgery to determine the presence of cancerous lesions, and have not received anti-cancer therapy in the past five years. All participants sign an informed consent to provide their tissue to research after pathology review.


In the trial, titled “JMC-Xeno 01: Development of patient-derived tissue transplant models for lung and breast cancer,” research scientists at Scripps Florida will analyze the tissue from the biopsy to learn more about cancer mutations affecting DNA, RNA and protein expression in tumors. There is great potential for future cancer treatments that may someday benefit patients, according to Jupiter Medical Center’s Clinical Research Department. For more information on the clinical trials conducted at Jupiter Medical Center, contact Jupiter Medical Center’s Clinical Research Department at (561) 263-5791 or visit jupitermed.com/clinical-research.

About Jupiter Medical Center's Clinical Research Program

Access to clinical trials is an integral component of Jupiter Medical Center’s (JMC) mission to improve the health and well-being of the community. Clinical trials may offer the opportunity to receive a new or potentially more effective therapy for diseases and certain medical conditions. JMC participates in national clinical studies addressing many aspects of cancer care, including new forms of treatment, methods of prevention, ways of screening for cancer and ways to improve comfort and quality of life for patients. Clinical trials offered at Jupiter Medical Center include oncology-related trials, disease-specific trials such as surgery studies, biospecimen trials, hyperbaric oxygen trials, infectious disease studies and prevention trials. For more information on the Clinical Research Program, visit jupitermed.com/clinical-research.


About Jupiter Medical Center
A not-for-profit 283-bed regional medical center consisting of 163 private acute care hospital beds and 120 long-term care, sub-acute rehabilitation and Hospice beds, Jupiter Medical Center provides a broad range of services with specialty concentrations in oncology, imaging, orthopedics & spine, digestive health, emergency services, lung & thoracic, women’s health, weight management and men’s health. Founded in 1979, the Medical Center has approximately 1,500 team members, 575 physicians and 640 volunteers. For more information on Jupiter Medical Center, please call (561) 263-2234 or visit Jupitermed.com.
 

About The Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 3,000 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including three Nobel laureates—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu.

# # #

Related Document
Press Releases- PR 2014